Related Experiment Videos
Treatment of unstable angina with cholesterol embolization as a complication of left heart catheterization
Japanese Circulation Journal
|May 1, 1990
Insights
Cholesterol embolization is a risk following femoral artery catheterization. Postmortem studies suggest brachial artery access for percutaneous coronary angioplasty (PTCA) may be safer in affected patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Pathology
Background:
- Cholesterol embolization syndrome (CES) is a serious complication following invasive cardiovascular procedures.
- Left heart catheterization, particularly via the femoral route, has been associated with CES.
Observation:
- Three cases of CES are presented following left heart catheterization performed via the femoral artery.
- All reported instances of CES in this context occurred after femoral artery catheterization.
Findings:
- Postmortem examinations were conducted on the patients.
- Percutaneous transluminal coronary angioplasty (PTCA) via the right brachial approach was identified as the safest treatment strategy.
- This approach is recommended for patients with intractable angina and evidence of CES.
Implications:
- The findings suggest a preferred arterial access route for specific patient populations.
- This highlights the importance of considering alternative approaches to minimize procedural risks.
- Further research may validate the safety and efficacy of the brachial approach in CES patients.
Abstract:
We describe 3 patients with cholesterol embolization after left heart catheterization via the femoral route. The left catheterizations were performed via the femoral route in all reported cases in which cholesterol embolization occurred as a complication of left catheterization. Postmortem examinations reveal that PTCA, using the right brachial approach, is the safest method for treatment of intractable angina in patients with evidence of cholesterol embolization.